BioCentury | Jan 22, 2020
Emerging Company Profile

Relay’s protein motion platform approaches clinical starting line

...partners: None Number of employees: About 120 Funds raised: $520 million Investors: Third Rock Ventures, D.E. Shaw Research...
BioCentury | Dec 21, 2018
Financial News

Relay runs away with $400M series C on back of protein conformation platform

...20, as did existing investors GV, Casdin Capital, BVF Partners, EcoR1 Capital, an affiliate of D.E. Shaw Research...
BioCentury | Dec 20, 2018
Financial News

Relay runs away with $400M series C on back of protein conformation platform

...round, as did existing investors GV, Casdin Capital, BVF Partners, EcoR1 Capital, an affiliate of D.E. Shaw Research...
BioCentury | Jun 17, 2013
Company News

D.E. Shaw Research, Zealand Pharma deal

...binding modes of the molecules on an undisclosed cardiovascular receptor target selected by the partners. D.E. Shaw Research LLC...
BioCentury | May 29, 2008
Cover Story

Cancer Grows on SOD1

...associate director of biology at Attenuon and included scientists from Cold Spring Harbor Laboratory and D.E. Shaw Research...
...Attenuon LLC , San Diego, Calif. Cold Spring Harbor Laboratory , Cold Spring Harbor, N.Y. D.E. Shaw Research...
Items per page:
1 - 5 of 5
BioCentury | Jan 22, 2020
Emerging Company Profile

Relay’s protein motion platform approaches clinical starting line

...partners: None Number of employees: About 120 Funds raised: $520 million Investors: Third Rock Ventures, D.E. Shaw Research...
BioCentury | Dec 21, 2018
Financial News

Relay runs away with $400M series C on back of protein conformation platform

...20, as did existing investors GV, Casdin Capital, BVF Partners, EcoR1 Capital, an affiliate of D.E. Shaw Research...
BioCentury | Dec 20, 2018
Financial News

Relay runs away with $400M series C on back of protein conformation platform

...round, as did existing investors GV, Casdin Capital, BVF Partners, EcoR1 Capital, an affiliate of D.E. Shaw Research...
BioCentury | Jun 17, 2013
Company News

D.E. Shaw Research, Zealand Pharma deal

...binding modes of the molecules on an undisclosed cardiovascular receptor target selected by the partners. D.E. Shaw Research LLC...
BioCentury | May 29, 2008
Cover Story

Cancer Grows on SOD1

...associate director of biology at Attenuon and included scientists from Cold Spring Harbor Laboratory and D.E. Shaw Research...
...Attenuon LLC , San Diego, Calif. Cold Spring Harbor Laboratory , Cold Spring Harbor, N.Y. D.E. Shaw Research...
Items per page:
1 - 5 of 5